PG Electroplast Limited has withdrawn the earnings conference call previously scheduled for May 20, 2026. The meeting, intended to discuss the financial performance for the quarter and financial year ended March 31, 2026, was cancelled due to a medical exigency on the part of a Key Managerial Personnel of the company. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Reason for Cancellation

The company stated that the withdrawal of the intimation regarding the schedule of the Analysts/ Investors Meeting is solely due to the medical emergency. PG Electroplast clarified that apart from the explanation provided, there is no other reason for the rescheduling or postponement of the conference call.

Future Schedule

PG Electroplast has confirmed that it will intimate the fresh schedule of the Analysts/ Investors Meeting/Conference Call in due course of time. The company aims to ensure all stakeholders are informed about the new dates for the discussion on its financial results.

Previous Meeting Details

The cancelled conference call was organized by JM Financial Institutional Securities Limited and was classified as a group meet. Senior officials, including Mr. Vishal Gupta – Managing Director (Finance) and Mr. Pramod Gupta – Chief Financial Officer, were initially slated to participate. The disclosure regarding the withdrawal was signed by Deepesh Kedia, Company Secretary, on May 15, 2026.

PG Electroplast has notified the stock exchanges of an upcoming Board of Directors meeting scheduled for Tuesday, May 19, 2026, to be conducted via video conferencing. The intimation has been filed pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice was signed by Company Secretary Deepesh Kedia and dated May 12, 2026, from Pune.

Board Meeting Agenda

The board meeting has been convened to transact the following key businesses:

The board will consider and approve the audited financial results — both standalone and consolidated — along with the report of the statutory auditors for the quarter and financial year ended March 31, 2026. Additionally, the board will deliberate on the recommendation of a final dividend, if any, for the financial year ended March 31, 2026.

Trading Window Closure

In accordance with the Company's Code of Conduct for Prohibition of Insider Trading, framed under the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for all Directors, Key Managerial Personnel, Designated Persons, and their immediate relatives has been closed. The trading window closure is in effect from April 01, 2026 and will continue until May 21, 2026.

The filing was made to both BSE Limited and the National Stock Exchange of India Limited as part of the company's regulatory disclosure obligations.